StockWatch: Antitrust Fears Dampen Support for $43B Pfizer-Seagen Deal
Pfizer's planned $43 billion purchase of Seagen didn't spark the usual huge stock surge, due to antitrust review concerns.
Source: genengnews.com
Page 6 - Dane Leone News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Dane Leone. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Dane Leone Today - Breaking & Trending Today
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen. Thank you for standing by and welcome to the Ocular Therapeutix Fourth Quarter and Year-End 2022 Earnings Conference Call.
Source: insidermonkey.com
Cytokinetics, Incorporated (NASDAQ:CYTK) Q4 2022 Earnings Call Transcript
Operator: Good afternoon and welcome ladies and gentlemen to Cytokinetics' Fourth Quarter 2022 Conference Call.
Source: insidermonkey.com
REGENXBIO Inc. (NASDAQ:RGNX) Q4 2022 Earnings Call Transcript
Operator: Hello, and thank you for standing by. Welcome to the Q4 and Full Year 2022 REGENXBIO Earnings Call. At this time, all participants are in a listen-only mode.
Source: insidermonkey.com